Considerations and controversies in managing chronic kidney disease: An update-Reference-Cited by-同舟云学术

Considerations and controversies in managing chronic kidney disease: An update

Published:2017-06-01 Issue:11 Volume:74 Page:795-810
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Prasad-Reddy Lalita¹,Isaacs Diana²,Kantorovich Alexander³

Affiliation:

1. Chicago State University, Chicago, IL; and Rush University Medical Center, Chicago, IL

2. Cleveland Clinic Diabetes Center, Cleveland, OH

3. Chicago State University College of Pharmacy, Chicago, IL; and Advocate Christ Medical Center, Oak Lawn, IL

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/74/11/795/28336110/ajhp0795.pdf

Reference79 articles.

1. Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes;Molitch;Kidney Int,2015

2. Centers for Disease Control and Prevention. National chronic kidney disease fact sheet, 2014. www.cdc.gov/diabetes/pubs/pdf/kidney_fact-sheet.pdf (accessed 2015 Aug 1).

3. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD);Kidney Disease: Improving Global Outcomes (KDIGO) Work Group;Kidney Int,2009

4. KDIGO clinical practice guideline for anemia in chronic kidney disease;Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group;Kidney Int Suppl,2012

5. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease;KDOQI, National Kidney Foundation;Am J Kidney Dis,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigational new drugs for the treatment of chronic renal failure: an overview of the literature;Expert Opinion on Investigational Drugs;2024-03-28

2. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications;Life Sciences;2022-12

3. Thromboxane A2 is involved in the development of hypertension in chronic kidney disease rats;European Journal of Pharmacology;2021-10

4. Effects of Jianpi Bushen Therapy for Treatment of CKD Anemia: A Meta-Analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2020-09-15

5. Role of Artificial Intelligence in Kidney Disease;International Journal of Medical Sciences;2020